Cargando…

Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using (18)F–FDG-PET-CT and/or diffusion-weighted MRI

BACKGROUND: Considerable variation exists in diagnostic tests used for local response evaluation after chemoradiation in patients with advanced oropharyngeal cancer. The yield of invasive examination under general anesthesia (EUA) with biopsies in all patients is low and it may induce substantial mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greuter, Marjolein JE, Schouten, Charlotte S, Castelijns, Jonas A, de Graaf, Pim, Comans, Emile FI, Hoekstra, Otto S, de Bree, Remco, Coupé, Veerle MH
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387392/ https://www.ncbi.nlm.nih.gov/pubmed/28399836 http://dx.doi.org/10.1186/s12885-017-3254-0

Ejemplares similares

The adverse impact of surveillance intervals on the sensitivity of FDG-PET/CT for the detection of distant metastases in head and neck cancer patients
por: Senft, Asaf, et al.
Publicado: (2016)

The Additional Value of Ultrafast DCE-MRI to DWI-MRI and 18F-FDG-PET to Detect Occult Primary Head and Neck Squamous Cell Carcinoma
por: Martens, Roland M., et al.
Publicado: (2020)

Interobserver Variability in Chest CT and Whole Body FDG-PET Screening for Distant Metastases in Head and Neck Cancer Patients
por: Senft, Asaf, et al.
Publicado: (2010)

Predictive value of quantitative (18)F-FDG-PET radiomics analysis in patients with head and neck squamous cell carcinoma
por: Martens, Roland M., et al.
Publicado: (2020)

Screening for distant metastases in head and neck cancer patients using FDG-PET and chest CT: validation of an algorithm
por: Senft, Asaf, et al.
Publicado: (2015)

Pretreatment screening for distant metastases in the Dutch head and neck centers: 10 years later
por: Senft, Asaf, et al.
Publicado: (2016)

Early Response Prediction of Multiparametric Functional MRI and (18)F-FDG-PET in Patients with Head and Neck Squamous Cell Carcinoma Treated with (Chemo)Radiation
por: Martens, Roland M., et al.
Publicado: (2022)

The cost-effectiveness of (18)FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy
por: van Hooren, Addy C. G., et al.
Publicado: (2008)

Multiparametric functional MRI and (18)F-FDG-PET for survival prediction in patients with head and neck squamous cell carcinoma treated with (chemo)radiation
por: Martens, Roland M., et al.
Publicado: (2020)

(18) F-FDG PET standard uptake values of the normal pons in children: establishing a reference value for diffuse intrinsic pontine glioma
por: Jansen, Marc H A, et al.
Publicado: (2014)

Is C‐11 Methionine PET an alternative to 18‐F FDG‐PET for identifying recurrent laryngeal cancer after radiotherapy?
por: Wedman, Jan, et al.
Publicado: (2018)

Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology
por: Cheebsumon, Patsuree, et al.
Publicado: (2012)

2-Deoxy-2[F-18]FDG-PET for Detection of Recurrent Laryngeal Carcinoma after Radiotherapy: Interobserver Variability in Reporting
por: van der Putten, L., et al.
Publicado: (2008)

The real additional value of FDG-PET in detecting the occult primary tumour in patients with cervical lymph node metastases of unknown primary tumour
por: de Bree, Remco
Publicado: (2010)

Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real‐world data
por: Jongeneel, Gabrielle, et al.
Publicado: (2019)

Standard chemoradiation versus intensity-modulated chemoradiation: a quality of life assessment in oropharyngeal cancer patients
por: Mowry, Sarah E., et al.
Publicado: (2009)

Bilateral Blindness Following Chemoradiation for Locally Advanced Oropharyngeal Carcinoma
por: Zeng, K. Liang, et al.
Publicado: (2015)

Assessing Novel Drugs and Radiation Technology in the Chemoradiation of Oropharyngeal Cancer
por: Cristaudo, Agostino, et al.
Publicado: (2018)

A predictive model for advanced oropharyngeal cancer patients treated with chemoradiation
por: Lo, Wu-Chia, et al.
Publicado: (2022)

Implementation of an optical diagnosis strategy saves costs and does not impair clinical outcomes of a fecal immunochemical test-based colorectal cancer screening program
por: Vleugels, Jasper L. A., et al.
Publicado: (2017)

On the Added Value of Baseline FDG-PET in Malignant Lymphoma
por: Quarles van Ufford, Henriette, et al.
Publicado: (2009)

Resilience of a FIT screening programme against screening fatigue: a modelling study
por: Greuter, Marjolein J. E., et al.
Publicado: (2016)

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
por: Boellaard, Ronald, et al.
Publicado: (2009)

Employment and return to work following chemoradiation in patient with HPV-related oropharyngeal cancer
por: Baxi, Shrujal S., et al.
Publicado: (2016)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2008)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2009)

Partial volume correction strategies for quantitative FDG PET in oncology
por: Hoetjes, Nikie J., et al.
Publicado: (2010)

Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study
por: van Wifferen, Francine, et al.
Publicado: (2022)

Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening
por: Worthington, Joachim, et al.
Publicado: (2023)

Clinical Utility of Multimodality Imaging with Dynamic Contrast-Enhanced MRI, Diffusion-Weighted MRI, and (18)F-FDG PET/CT for the Prediction of Neck Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiation
por: Ng, Shu-Hang, et al.
Publicado: (2014)

The cumulative false-positive rate in colorectal cancer screening: a Markov analysis
por: Haug, Ulrike, et al.
Publicado: (2020)

Feasibility of intraoperative detection of sentinel lymph nodes with 89-zirconium-labelled nanocolloidal albumin PET-CT and a handheld high-energy gamma probe
por: Heuveling, Derrek A., et al.
Publicado: (2018)

A Dosimetric Comparison of Primary Chemoradiation Versus Postoperative Radiation for Locally Advanced Oropharyngeal Cancer
por: Woo, Stanley K, et al.
Publicado: (2017)

18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation
por: David, John M., et al.
Publicado: (2019)

Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening
por: Bronzwaer, Maxime E. S., et al.
Publicado: (2018)

Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer
por: Robinson, Maxwell, et al.
Publicado: (2020)

Variability in quantitative analysis of atherosclerotic plaque inflammation using (18)F-FDG PET/CT
por: Lensen, Karel-Jan D. F., et al.
Publicado: (2017)

Anemia and neutrophil-to-lymphocyte ratio are prognostic in p16-positive oropharyngeal carcinoma treated with concurrent chemoradiation
por: Gorphe, Philippe, et al.
Publicado: (2017)

Preservation of swallowing function with de-intensified chemoradiation therapy for HPV-associated oropharyngeal squamous cell carcinoma
por: Judy, Greg D., et al.
Publicado: (2018)

The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases
por: Nielsen, Karin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_iqqhp504jukop5cvtjkcb1kj21